sabcs2020: triple negativer, metastasierter brustkrebs: neue therapieoption mit sacituzumab govi...
Published 3 years ago • 19 plays • Length 5:57Download video MP4
Download video MP3
Similar videos
-
2:40
dr. bardia on sacituzumab govitecan in triple-negative breast cancer
-
5:16
study of sacituzumab govitecan for triple-negative breast cancer
-
3:10
ascent trial: sacituzumab govitecan for tnbc
-
4:59
study of saci-io for hormone receptor positive metastatic breast cancer
-
1:28
highlights from sabcs 2020
-
11:35
sabcs 2022: primary results of the randomized, phase 3 study destiny-breast02 q & a
-
12:19
sabcs 2022: updated survival results of the randomized, phase 3 study destiny-breast03 q & a
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
2:00
ghs doctors use new technology to locate breast cancer
-
2:21
phase iii extenet trial at the 2020 sabcs
-
0:42
teaser: new treatment for triple negative metastatic breast cancer
-
1:03
dr. sabine siesling on mastectomies versus breast conserving surgery
-
2:16
sabcs 2022: destiny-breast02 destiny-breast03
-
1:00:59
2020 embrace metastatic breast cancer virtual forum series | research update for triple-negative mbc
-
3:40
breast cancer sub-types - triple negative breast cancer
-
1:51
suandok breast cancer network - sparc mbc challenge grant awardee
-
1:49
cobimetinib plus paclitaxel in tnbc
-
1:11
dr. sparano discusses unmet needs in metastatic breast cancer